← Back to Search

Behavioural Intervention

App-Based CBT for Postpartum Depression

Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Screening 3 weeks
Treatment Varies
Follow Up baseline (32-36 weeks' gestation), within one week of delivery, 2 months postpartum, 4 months postpartum, and 6 months postpartum
Awards & highlights


This trial is testing a new smartphone app called M.Bapp, based on the Mothers & Babies Program, to help prevent postpartum depression in high-risk mothers. The app is being studied to see

Who is the study for?
This trial is for new mothers who may be at high risk of postpartum depression, which can affect up to 25% of mothers with certain risk factors. The study is open to those without a prior history of depression and aims to help prevent PPD through an app-based program.Check my eligibility
What is being tested?
The trial tests the feasibility and acceptability of M.Bapp, an app that delivers cognitive behavioral therapy (CBT) based education for preventing postpartum depression. It's adapted from the Mothers & Babies Program recommended by US Preventive Services Task Force.See study design
What are the potential side effects?
Since this intervention involves educational content delivered via an app, there are no direct medical side effects like you would expect with medication. However, users might experience discomfort or stress related to engaging with the material.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Secondary outcome measures
Dyadic Adjustment Scale
Frequency of Mothers and Babies Skills Use
General Anxiety Disorder-7
+3 more
Other outcome measures
De novo psychiatric diagnosis
Screening positive on study survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: M.BappExperimental Treatment1 Intervention
M.Bapp contains the same app-based digital parenting education provided to the active comparator group as well as 9 additional interactive modules based on the MB cognitive behavioral therapy curriculum. M.Bapp contains interactive features and EMA-based voluntary daily assignments that provide the opportunity to receive additional final reimbursement. Those who complete all modules will receive a digital certificate of completion.
Group II: App-based digital parenting educationActive Control1 Intervention
App-based digital parenting education will be delivered through a smartphone app with similar features as M.Bapp, but the content delivered through this attention-matched control app will not contain any CBT modules or psychoeducation.

Find a Location

Who is running the clinical trial?

Women and Infants Hospital of Rhode IslandLead Sponsor
110 Previous Clinical Trials
38,753 Total Patients Enrolled
~40 spots leftby May 2025